Modalis Therapeutics

4883.TTSE GROWTHPharmaceutical
Major holders (5%+) · 3
HolderStakeChangeFiled
Evo Fund7.61%-1.35pp2026-10-22
Life Science Innovation Management Inc.6.28%-9.02pp2025-08-12
LSIM Inc.5.02%-0.21pp2026-05-27

Each holder's own ratio from its most recent large-shareholding report.

Former and minor holders (below 5%) · 5
SBI SECURITIES Co., Ltd.3.77%2025-01-22
Osamu Nureki3.58%2024-09-25
SBI Investment Co., Ltd.0.69%2025-01-22
Haruhiko Morita0.38%2026-05-27
Evolution Capital Management LLC0.00%2026-06-19
Ownership history · 177
FiledHolderRatioChangePurpose
2024-09-09AmendedSBI SECURITIES Co., Ltd.2024-09-09 · amended2.80%+1.54ppSecurities trading business
2024-09-05AmendedEvolution Capital Management LLC2024-09-05 · amended0.00%no changePure investment; Held for clients (discretionary / trust); Asset management / investment
2024-09-05AmendedEvo Fund2024-09-05 · amended41.14%-1.13ppPure investment
2024-09-02AmendedEvolution Capital Management LLC2024-09-02 · amended0.00%no changePure investment; Held for clients (discretionary / trust); Asset management / investment
2024-09-02AmendedEvo Fund2024-09-02 · amended42.27%-2.84ppPure investment
2024-08-30AmendedEvolution Capital Management LLC2024-08-30 · amended0.00%no changePure investment; Held for clients (discretionary / trust); Asset management / investment
2024-08-30AmendedEvo Fund2024-08-30 · amended45.11%+39.69ppPure investment
2024-08-28AmendedEvolution Capital Management LLC2024-08-28 · amended0.00%no changePure investment; Held for clients (discretionary / trust); Asset management / investment
2024-08-28AmendedEvo Fund2024-08-28 · amended5.42%-1.20ppPure investment
2024-08-20AmendedEvolution Capital Management LLC2024-08-20 · amended0.00%no changePure investment; Held for clients (discretionary / trust); Asset management / investment
2024-08-20AmendedEvo Fund2024-08-20 · amended6.62%no changePure investment
2024-08-19AmendedEvolution Capital Management LLC2024-08-19 · amended0.00%no changePure investment; Held for clients (discretionary / trust); Asset management / investment
2024-08-19AmendedEvo Fund2024-08-19 · amended6.62%-1.56ppPure investment
2024-08-16AmendedEvolution Capital Management LLC2024-08-16 · amended0.00%no changePure investment; Held for clients (discretionary / trust); Asset management / investment
2024-08-16AmendedEvo Fund2024-08-16 · amended8.18%-3.33ppPure investment
2024-08-09AmendedHaruhiko Morita2024-08-09 · amended0.92%-0.23ppStable shareholder; Long-term holding
2024-08-09AmendedLife Science Innovation Management Inc.2024-08-09 · amended12.25%+3.28ppStable shareholder
2024-08-02Same-day filingOsamu Nureki2024-08-025.11%-1.02ppStable shareholder
2024-08-02Same-day filingNUREKI OSAMU2024-08-026.13%newStable shareholder
2024-07-31AmendedEvolution Capital Management LLC2024-07-31 · amended0.00%no changePure investment; Held for clients (discretionary / trust); Asset management / investment

Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.